SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-19-007634
Filing Date
2019-05-16
Accepted
2019-05-16 15:25:07
Documents
48
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm 10-Q/A 41970
2 ex31-1.htm EX-31.1 20778
3 ex31-2.htm EX-31.2 20050
4 ex32-1.htm EX-32.1 10584
  Complete submission text file 0001493152-19-007634.txt   2299328

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ptix-20190331.xml EX-101.INS 473490
6 XBRL SCHEMA FILE ptix-20190331.xsd EX-101.SCH 35606
7 XBRL CALCULATION FILE ptix-20190331_cal.xml EX-101.CAL 36618
8 XBRL DEFINITION FILE ptix-20190331_def.xml EX-101.DEF 133423
9 XBRL LABEL FILE ptix-20190331_lab.xml EX-101.LAB 250070
10 XBRL PRESENTATION FILE ptix-20190331_pre.xml EX-101.PRE 195199
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-51353 | Film No.: 19832023
SIC: 7389 Services-Business Services, NEC